Skip to main content
Top
Published in: Comparative Clinical Pathology 2/2018

01-03-2018 | Original Article

Evaluation of lipid-lowering effect of Cynara scolymus extract-loaded mesoporous silica nanoparticles on ultra-lipid-fed mice

Authors: Amir Asadabadi Safat, Hassan Sheibani, Pourya Mohammadi, Navid Hasanabadi, Ehsanollah Sakhaee

Published in: Comparative Clinical Pathology | Issue 2/2018

Login to get access

Abstract

In current investigation, twenty mice were divided into 4 different equal groups as follows: group CS which received 0.1 ml Cynara scolymus extract (diluted in distilled water) at dose of 600 mg kg−1 daily for 3 weeks, group A which received 0.1 ml Atorvastatin 40 (diluted in distilled water) at dose of 20 mg kg−1 daily for 21 days, group T which received 0.1 ml of Cynara scolymus extract at dose of 600 mg kg−1 daily in nonporous (diluted in distilled water) during experimental period, and control group (group C) which received the same volume of normal saline. The supplements were gavaged in all animals, during experiment period, and blood samples were obtained after 21 days. Results showed that total cholesterol and triglyceride decreased significantly in the treatment group compared with the control and CS groups (p < 0.05). It seems that mesoporous silica nanoparticles improve drug delivery and therefore Cynara scolymus extract-loaded mesoporous silica nanoparticles has more effective lipid-lowering action than Cynara scolymus extract.
Literature
go back to reference Chaudhary A, Nagaich U, Gulati N, Sharma V, Khosa R, Partapur MU (2012) Enhancement of solubilization and bioavailability of poorly soluble drugs by physical and chemical modifications: a recent review. J Adv Pharm Educ Res 2:32–67 Chaudhary A, Nagaich U, Gulati N, Sharma V, Khosa R, Partapur MU (2012) Enhancement of solubilization and bioavailability of poorly soluble drugs by physical and chemical modifications: a recent review. J Adv Pharm Educ Res 2:32–67
go back to reference Chen Y et al (2009) Hollow/rattle-type mesoporous nanostructures by a structural difference-based selective etching strategy. ACS Nano 4:529–539CrossRef Chen Y et al (2009) Hollow/rattle-type mesoporous nanostructures by a structural difference-based selective etching strategy. ACS Nano 4:529–539CrossRef
go back to reference CONSULTATION E (2008) Committee on herbal medicinal products (HMPC) CONSULTATION E (2008) Committee on herbal medicinal products (HMPC)
go back to reference Dahlöf B (2010) Cardiovascular disease risk factors: epidemiology and risk assessment. Am J Cardiol 105:3A–9ACrossRefPubMed Dahlöf B (2010) Cardiovascular disease risk factors: epidemiology and risk assessment. Am J Cardiol 105:3A–9ACrossRefPubMed
go back to reference Javadzadeh Y, Mohammadi A, Khoei NS, Nokhodchi A (2009) Improvement of physicomechanical properties of carbamazepine by recrystallization at different pH values. Acta Pharma 59:187–197CrossRef Javadzadeh Y, Mohammadi A, Khoei NS, Nokhodchi A (2009) Improvement of physicomechanical properties of carbamazepine by recrystallization at different pH values. Acta Pharma 59:187–197CrossRef
go back to reference Khalil R, Abuharfeil N, Shabsoug B (2008) The effect of Crataegus aronica aqueous extract in rabbits fed with high cholesterol diet. Eur J Sci Res 22:352–360 Khalil R, Abuharfeil N, Shabsoug B (2008) The effect of Crataegus aronica aqueous extract in rabbits fed with high cholesterol diet. Eur J Sci Res 22:352–360
go back to reference Mulvihill EE, Huff MW (2010) Antiatherogenic properties of flavonoids: implications for cardiovascular health. Can J Cardiol 26:17A–21ACrossRefPubMed Mulvihill EE, Huff MW (2010) Antiatherogenic properties of flavonoids: implications for cardiovascular health. Can J Cardiol 26:17A–21ACrossRefPubMed
go back to reference Pasupathia P, Saravanan G, Raoc Y, Farookc J, Bakthavathsalamc G (2009) Effective analysis of atorvastatin versus in simvastatin patients with hyperlipidemia. J Pharm Sci Res 1:16–21 Pasupathia P, Saravanan G, Raoc Y, Farookc J, Bakthavathsalamc G (2009) Effective analysis of atorvastatin versus in simvastatin patients with hyperlipidemia. J Pharm Sci Res 1:16–21
go back to reference Shimoda H, Ninomiya K, Nishida N, Yoshino T, Morikawa T, Matsuda H, Yoshikawa M (2003) Anti-hyperlipidemic sesquiterpenes and new sesquiterpene glycosides from the leaves of artichoke (Cynara scolymus L.): structure requirement and mode of action. Bioorg Med Chem Lett 13:223–228CrossRefPubMed Shimoda H, Ninomiya K, Nishida N, Yoshino T, Morikawa T, Matsuda H, Yoshikawa M (2003) Anti-hyperlipidemic sesquiterpenes and new sesquiterpene glycosides from the leaves of artichoke (Cynara scolymus L.): structure requirement and mode of action. Bioorg Med Chem Lett 13:223–228CrossRefPubMed
Metadata
Title
Evaluation of lipid-lowering effect of Cynara scolymus extract-loaded mesoporous silica nanoparticles on ultra-lipid-fed mice
Authors
Amir Asadabadi Safat
Hassan Sheibani
Pourya Mohammadi
Navid Hasanabadi
Ehsanollah Sakhaee
Publication date
01-03-2018
Publisher
Springer London
Published in
Comparative Clinical Pathology / Issue 2/2018
Print ISSN: 1618-5641
Electronic ISSN: 1618-565X
DOI
https://doi.org/10.1007/s00580-017-2621-1

Other articles of this Issue 2/2018

Comparative Clinical Pathology 2/2018 Go to the issue